Tectonic Advisors LLC Eli Lilly & CO Transaction History

Tectonic Advisors LLC

$1.36 Billion
Q2 2024

A detailed history of Tectonic Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tectonic Advisors LLC holds 3,338 shares of LLY stock, worth $2.97 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

3,338

Previous 3,334 0.12%

Holding current value

$2.97 Million

Previous $2.59 Million 16.54%

% of portfolio

0.22%

Previous 0.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $2,899 - $3,636	4 Added 0.12%	3,338 $3.02 Million
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $1,776 - $2,376	3 Added 0.09%	3,334 $2.59 Million
Q4 2023 Jan 17, 2024	BUY	$525.19 - $619.13 $7,352 - $8,667	14 Added 0.42%	3,331 $1.94 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $120,846 - $166,605	278 Added 9.15%	3,317 $1.78 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $3,156 - $4,220	9 Added 0.3%	3,039 $1.43 Million
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $3,416 - $4,013	11 Added 0.36%	3,030 $1.04 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $1,286 - $1,498	-4 Reduced 0.13%	3,019 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $10,870 - $12,763	-39 Reduced 1.27%	3,023 $980,000
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $6,070 - $7,534	-27 Reduced 0.87%	3,062 $846,000
Q3 2021 Nov 02, 2021	SELL	$221.6 - $272.71 $26,148 - $32,179	-118 Reduced 3.68%	3,089 $714,000
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $1,444 - $1,868	-8 Reduced 0.25%	3,207 $736,000
Q1 2021 May 18, 2021	BUY	$164.32 - $212.72 $6,901 - $8,934	42 Added 1.32%	3,215 $601,000
Q4 2020 May 17, 2021	BUY	$130.46 - $172.63 $413,949 - $547,754	3,173 New	3,173 $536,000

Others Institutions Holding LLY

# of Institutions

3,871

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tectonic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tectonic Advisors LLC with notifications on news.

Account

Tectonic Advisors LLC Eli Lilly & CO Transaction History